| 1 |
34371436 |
10.1016/j.leukres.2021.106683 |
2022 |
Proposal and clinical application of molecular genetic risk scoring system, MRplus, for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre. |
EBF1 |
| 2 |
34461601 |
10.1016/j.ebiom.2021.103559 |
2022 |
Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers. |
EBF1 |
| 3 |
34657128 |
10.1038/s41375-021-01448-2 |
2022 |
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. |
EBF1 |
| 4 |
35182476 |
10.1016/j.molcel.2022.01.015 |
2022 |
EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells. |
EBF1 |
| 5 |
35245453 |
10.1016/j.molcel.2022.02.015 |
2022 |
How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch. |
EBF1 |
| 6 |
35289450 |
10.1111/ped.14955 |
2022 |
Early diagnosis of EBF1-PDGFRB-positive acute lymphoblastic leukemia. |
EBF1 |
| 7 |
35650277 |
10.1038/s41416-022-01806-6 |
2022 |
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions. |
EBF1 |
| 8 |
30335886 |
10.1002/jcb.27177 |
2021 |
EBF1 gene promotes the proliferation and inhibits the apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome through negative regulation of mitogen-activated protein kinase axis. |
EBF1 |
| 9 |
31558067 |
10.1080/10428194.2019.1668938 |
2021 |
Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with <i>Ebf1-Pdgfrb</i> fusion transcript. |
EBF1 |
| 10 |
32068648 |
10.1097/MPH.0000000000001743 |
2021 |
B-Cell Precursor-Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature Review. |
EBF1 |
| 11 |
32364535 |
10.1172/JCI126726 |
2021 |
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer. |
EBF1 |
| 12 |
32467145 |
10.3324/haematol.2020.247973 |
2021 |
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. |
EBF1 |
| 13 |
32592278 |
10.1002/gcc.22882 |
2021 |
Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol. |
EBF1 |
| 14 |
33004416 |
10.1101/gad.340216.120 |
2021 |
EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism. |
EBF1 |
| 15 |
33150465 |
10.1007/s00277-020-04332-8 |
2021 |
Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion. |
EBF1 |
| 16 |
33369444 |
10.31557/APJCP.2020.21.12.3493 |
2021 |
Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis. |
EBF1 |
| 17 |
33395752 |
10.1016/j.tranon.2020.100977 |
2021 |
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation. |
EBF1 |
| 18 |
33452395 |
10.1038/s41598-021-81000-5 |
2021 |
EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex. |
EBF1 |
| 19 |
33619557 |
10.1182/blood.2020009564 |
2021 |
EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene. |
EBF1 |
| 20 |
33646306 |
10.1182/bloodadvances.2020001844 |
2021 |
Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia. |
EBF1 |
| 21 |
33707599 |
10.1038/s41598-021-85213-6 |
2021 |
Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan. |
EBF1 |
| 22 |
34535769 |
10.1038/s41388-021-02012-z |
2021 |
Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia. |
EBF1 |
| 23 |
34824268 |
10.1038/s41467-021-27232-5 |
2021 |
Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation. |
EBF1 |
| 24 |
29931583 |
10.1007/s10637-018-0623-8 |
2020 |
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2. |
EBF1 |
| 25 |
30874617 |
10.1038/s41598-019-41078-4 |
2020 |
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia. |
EBF1 |
| 26 |
32054837 |
10.1038/s41467-019-14152-8 |
2020 |
Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus. |
EBF1 |
| 27 |
32522871 |
10.1073/pnas.1921139117 |
2020 |
Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis. |
EBF1 |
| 28 |
32661308 |
10.1038/s41598-020-68311-9 |
2020 |
MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia. |
EBF1 |
| 29 |
29348129 |
10.1182/blood-2017-07-796862 |
2019 |
Genomic CDKN2A/2B deletions in adult Ph<sup>+</sup> ALL are adverse despite allogeneic stem cell transplantation. |
EBF1 |
| 30 |
29407587 |
10.1016/j.leukres.2018.01.012 |
2019 |
High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction. |
EBF1 |
| 31 |
29498923 |
10.1200/JCO.2017.74.3617 |
2019 |
IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. |
EBF1 |
| 32 |
29946193 |
10.1038/s41375-018-0178-x |
2019 |
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. |
EBF1 |
| 33 |
30381291 |
10.1101/gr.233585.117 |
2019 |
LTRs activated by Epstein-Barr virus-induced transformation of B cells alter the transcriptome. |
EBF1 |
| 34 |
27166193 |
10.18632/oncotarget.9210 |
2018 |
Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis. |
EBF1 |
| 35 |
27339065 |
10.1080/10428194.2016.1193855 |
2018 |
Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia. |
EBF1 |
| 36 |
27460500 |
10.1038/ncomms12320 |
2018 |
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. |
EBF1 |
| 37 |
28555080 |
10.1038/leu.2017.166 |
2018 |
Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis. |
EBF1 |
| 38 |
28631637 |
10.4103/IJPM.IJPM_466_16 |
2018 |
An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemia. |
EBF1 |
| 39 |
28886309 |
10.14715/cmb/2017.63.8.4 |
2018 |
The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia. |
EBF1 |
| 40 |
29467311 |
10.1128/JVI.02155-17 |
2018 |
Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300. |
EBF1 |
| 41 |
29575541 |
10.1111/ijlh.12805 |
2018 |
Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel. |
EBF1 |
| 42 |
30203896 |
10.1002/gcc.22664 |
2018 |
Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases. |
EBF1 |
| 43 |
26872634 |
10.1182/blood-2015-09-670166 |
2017 |
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications. |
EBF1 |
| 44 |
26957068 |
10.3760/cma.j.issn.0578-1310.2016.03.011 |
2017 |
[Copy number variations in pediatric ETV6/RUNX1 positive acute lymphoblastic leukemia]. |
EBF1 |
| 45 |
27664237 |
10.1101/gad.283762.116 |
2017 |
Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia. |
EBF1 |
| 46 |
27855558 |
10.1080/10428194.2016.1219902 |
2017 |
Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). |
EBF1 |
| 47 |
27979924 |
10.3324/haematol.2016.153023 |
2017 |
Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients. |
EBF1 |
| 48 |
28045622 |
10.1200/JCO.2016.69.6278 |
2017 |
Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. |
EBF1 |
| 49 |
28193567 |
10.1016/j.leukres.2017.01.034 |
2017 |
Genomic analysis of adult B-ALL identifies potential markers of shorter survival. |
EBF1 |
| 50 |
28202519 |
10.1158/0008-5472.CAN-16-2571 |
2017 |
Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia. |
EBF1 |
| 51 |
28369050 |
10.1038/ni.3716 |
2017 |
Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. |
EBF1 |
| 52 |
28401483 |
10.1007/s12032-017-0940-3 |
2017 |
Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients. |
EBF1 |
| 53 |
28439887 |
10.1111/bjh.14721 |
2017 |
Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts. |
EBF1 |
| 54 |
28476192 |
10.1016/j.arcmed.2016.12.005 |
2017 |
Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse. |
EBF1 |
| 55 |
28655536 |
10.1016/j.exphem.2017.06.004 |
2017 |
B-cell identity as a metabolic barrier against malignant transformation. |
EBF1 |
| 56 |
26194343 |
10.1002/cncr.29579 |
2016 |
Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols. |
EBF1 |
| 57 |
26311245 |
10.1128/CVI.00374-15 |
2016 |
Applied Protein and Molecular Techniques for Characterization of B Cell Neoplasms in Horses. |
EBF1 |
| 58 |
26468528 |
10.1128/JVI.02318-15 |
2016 |
Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival. |
EBF1 |
| 59 |
26781410 |
|
2016 |
[Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification]. |
EBF1 |
| 60 |
26788497 |
10.1155/2015/165238 |
2016 |
ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. |
EBF1 |
| 61 |
26819314 |
10.1128/JVI.03227-15 |
2016 |
Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor. |
EBF1 |
| 62 |
24970810 |
10.18632/oncotarget.2080 |
2015 |
Mutational analysis of primary central nervous system lymphoma. |
EBF1 |
| 63 |
25044358 |
10.1002/gcc.22201 |
2015 |
Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan. |
EBF1 |
| 64 |
25261097 |
10.3324/haematol.2014.112912 |
2015 |
Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia. |
EBF1 |
| 65 |
25748621 |
10.5604/17322693.1142719 |
2015 |
Genes and childhood leukemia. |
EBF1 |
| 66 |
25990863 |
10.1182/blood-2014-12-575688 |
2015 |
Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia. |
EBF1 |
| 67 |
23823658 |
10.1038/leu.2013.206 |
2014 |
Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011. |
EBF1 |
| 68 |
24186319 |
10.3324/haematol.2013.095372 |
2014 |
Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion. |
EBF1 |
| 69 |
24362818 |
10.1038/ng.2856 |
2014 |
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. |
EBF1 |
| 70 |
22808135 |
10.1371/journal.pone.0040332 |
2013 |
Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma. |
EBF1 |
| 71 |
22848414 |
10.1371/journal.pone.0040934 |
2013 |
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia. |
EBF1 |
| 72 |
23174882 |
10.1038/leu.2012.280 |
2013 |
Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma. |
EBF1 |
| 73 |
23775715 |
10.1182/blood-2013-04-495804 |
2013 |
A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma. |
EBF1 |
| 74 |
23835704 |
10.1200/JCO.2012.47.6770 |
2013 |
Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia. |
EBF1 |
| 75 |
24081948 |
10.1084/jem.20130497 |
2013 |
Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia. |
EBF1 |
| 76 |
20435627 |
10.3324/haematol.2009.011114 |
2012 |
Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia. |
EBF1 |
| 77 |
22472950 |
10.1038/mt.2012.59 |
2012 |
Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia. |
EBF1 |
| 78 |
22851563 |
10.1200/JCO.2011.40.3907 |
2012 |
IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. |
EBF1 |
| 79 |
22897847 |
10.1016/j.ccr.2012.06.005 |
2012 |
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. |
EBF1 |
| 80 |
20699438 |
10.1182/blood-2009-08-239681 |
2011 |
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. |
EBF1 |
| 81 |
21606506 |
10.1084/jem.20101947 |
2011 |
Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia. |
EBF1 |
| 82 |
21628403 |
10.1182/blood-2011-02-338848 |
2011 |
Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice. |
EBF1 |
| 83 |
20227268 |
10.1016/j.coi.2010.02.004 |
2010 |
STAT5 in B cell development and leukemia. |
EBF1 |
| 84 |
20357822 |
10.1038/leu.2010.40 |
2010 |
AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model. |
EBF1 |
| 85 |
20445578 |
10.1038/leu.2010.87 |
2010 |
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. |
EBF1 |
| 86 |
19129520 |
10.1056/NEJMoa0808253 |
2009 |
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. |
EBF1 |
| 87 |
19138562 |
10.1016/S1470-2045(08)70339-5 |
2009 |
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. |
EBF1 |
| 88 |
18458336 |
10.1073/pnas.0800408105 |
2008 |
Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease. |
EBF1 |
| 89 |
18768390 |
10.1182/blood-2008-06-165027 |
2008 |
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. |
EBF1 |
| 90 |
18957548 |
10.1073/pnas.0803494105 |
2008 |
Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer. |
EBF1 |
| 91 |
17344859 |
10.1038/nature05690 |
2007 |
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. |
EBF1 |
| 92 |
17456056 |
10.1111/j.1365-2141.2007.06583.x |
2007 |
Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis. |
EBF1 |
| 93 |
16147992 |
10.1074/mcp.M500112-MCP200 |
2006 |
Analysis of BCL6-interacting proteins by tandem mass spectrometry. |
EBF1 |
| 94 |
15544702 |
10.1186/1471-2407-4-80 |
2005 |
Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression. |
EBF1 |
| 95 |
12393497 |
10.1182/blood-2002-08-2652 |
2003 |
Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Krüppel-like zinc finger protein. |
EBF1 |
| 96 |
12406913 |
10.1182/blood-2002-06-1797 |
2003 |
Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. |
EBF1 |
| 97 |
8703122 |
10.1007/s003359900205 |
1996 |
Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence. |
EBF1 |
| 98 |
1399124 |
10.1002/ijc.2910520324 |
1992 |
Activation of c-fos and c-fes in metastatic lympho-macrophage hybrids. |
EBF1 |
Datasets
Models
